Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Real-world data on predictors of survival in patients with gynecological tumors following pelvic arterial embolization
DOI: 10.22514/ejgo.2026.022
Incidence and clinical course of lymphoceles following pelvic sentinel lymph node removal in endometrial cancer
DOI: 10.22514/ejgo.2026.023
Comparative outcomes of MPPE and segmental rectosigmoid resection in cytoreductive surgery for advanced ovarian cancer
DOI: 10.22514/ejgo.2026.025
p53 protein expression, TP53 gene mutations, and in silico p53 activity as prognostic markers for ovarian cancer
DOI: 10.22514/ejgo.2026.028
Breast cancer: is the current screening appropriate?The RISCAM study
DOI: 10.22514/ejgo.2026.029
Clinicopathological significance of immunohistochemical expression of p53 and PTEN in endometrial carcinoma
DOI: 10.22514/ejgo.2026.031
Successful treatment of primary non-gestational choriocarcinoma of the uterine cervix in a postmenopausal woman
DOI: 10.22514/ejgo.2026.032
Eflapegrastim-induced large vessel vasculitis in patient treated with recurrent uterine leiomyosarcoma
DOI: 10.22514/ejgo.2026.034
A case of complete uterine prolapse complicated by cervical squamous cell carcinoma likely unrelated to HPV
DOI: 10.22514/ejgo.2026.035
Correction: PRDM6 promoter methylation as a potential epigenetic biomarker in BRCA-associated ovarian cancer
DOI: 10.22514/ejgo.2026.036
Correction: Subjective perceptions of breast cancer treatment experiences in women: a Q methodological approach
DOI: 10.22514/ejgo.2026.037
Correction: CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model
DOI: 10.22514/ejgo.2026.038
Correction: Three serum miRNAs as potential biomarkers for early diagnosis of cervical cancer
DOI: 10.22514/ejgo.2026.039
Correction: Prognostic value of Ki-67 in patients with ovarian cancer
DOI: 10.22514/ejgo.2026.040
Correction: Cancer screening behaviors and health literacy levels of women aged 30 and over in the northwest Turkey
DOI: 10.22514/ejgo.2026.042
Correction: Investigating the relationship between breast cancer and the postmenopausal period: a systematic meta-analysis
DOI: 10.22514/ejgo.2026.044
Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2
DOI: 10.22514/ejgo.2026.050
Correction: FOXK2 affects the motility of endometrial cancer cells by mediating ZEB1
DOI: 10.22514/ejgo.2026.052
Correction: CPNE1 as prognostic marker and regulator of cell growth and glycolysis in endometrial cancer
DOI: 10.22514/ejgo.2026.053
Correction: SHCBP1 a potential target in ovarian cancer growth and stemness
DOI: 10.22514/ejgo.2026.054
Correction: Risk factors contributing to the persistent infection of high-risk Human papillomavirus (HPV)
DOI: 10.22514/ejgo.2026.059
Correction: Delayed colposcopy outcomes and risk factors at a tertiary center in Turkey during the COVID-19 pandemic
DOI: 10.22514/ejgo.2026.060
Correction: The role of progesterone in ovarian cancer from pathogenesis to personalized therapy: an updated mini-review
DOI: 10.22514/ejgo.2026.061
Correction: Echinacoside suppresses cervical cancer by inhibiting cell growth and angiogenesis
DOI: 10.22514/ejgo.2026.063
Correction: FKBP10 ablation promotes breast cancer chemosensitivity via targeting autophagy and the AKT/CREB axis
DOI: 10.22514/ejgo.2026.064